PUBLIC CONTRACT · 2025
Fornecimento de Durvalumab, Osimertinib, Olaparib, Benralizumab Goserrelina ao Hospital de Santo Espírito da Ilha Terceira, EPER
- Contract value
- €443,876.98
- Signed on
- 18 March 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11291583PUBLISHED SUBJECT
Fornecimento de Durvalumab, Osimertinib, Olaparib, Benralizumab Goserrelina ao Hospital de Santo Espírito da Ilha Terceira, EPER
Parties involved
- Place of performance
- Portugal, Região Autónoma dos Açores, Angra do Heroismo
- NUTS region
- PT200 - Região Autónoma dos Açores
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ASTRAZENECA-PRODUTOS FARMACÊUTICOS,LDA. · Tax ID 502942240
Values and timeline
- Contract price
- €443,876.98
- Procedure base price
- €443,876.98
- Total effective price
- Not reported on Portal BASE
- Publication date
- 18 March 2025
- Award date
- 18 February 2025
- Signing date
- 18 March 2025
- Performance period
- 366 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 27/2015/A, de 29.12
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7344964
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.